DePuy Synthes

From WikiMD's WELLNESSPEDIA


DePuy Synthes







TypeSubsidiary
IndustryMedical Devices
ProductsOrthopedic and Neurosurgical Devices
Website[DePuy Synthes Official website]


DePuy Synthes is a global leader in the design, manufacture, and supply of orthopedic and neurosurgical devices. It is a subsidiary of Johnson & Johnson, one of the largest healthcare companies in the world.

History[edit]

DePuy was founded in 1895 by Revra DePuy in Warsaw, Indiana. The company initially focused on manufacturing fiber splints to set fractures. Over the years, DePuy expanded its product line to include a wide range of orthopedic devices.

In 1998, DePuy was acquired by Johnson & Johnson, further expanding its reach and capabilities in the medical device industry. In 2012, DePuy merged with Synthes, a Swiss company known for its trauma products, to form DePuy Synthes.

Products and Services[edit]

DePuy Synthes offers a comprehensive portfolio of products and services for the treatment of musculoskeletal conditions. These include:

Research and Development[edit]

DePuy Synthes is committed to advancing the field of orthopedic and neurosurgical care through continuous research and development. The company collaborates with leading surgeons and researchers to develop innovative solutions that improve patient outcomes.

Corporate Responsibility[edit]

As part of Johnson & Johnson, DePuy Synthes adheres to high standards of corporate responsibility. The company is dedicated to ethical business practices, sustainability, and improving global health.

See Also[edit]

References[edit]

External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.